Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Adherium Ltd. ( (AU:ADR) ) has provided an announcement.
Adherium Limited announced the late lodgement of two Appendices 3Y related to changes in notifiable interests, which were not due to on-market trades. The company assured stakeholders that this administrative oversight was an isolated incident and that their current compliance arrangements with ASX Listing Rules are adequate, requiring no additional steps.
More about Adherium Ltd.
Adherium Limited is a leading digital health company specializing in integrated digital health solutions and connected respiratory medical devices. The company is recognized globally for its Hailie® platform, which allows clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely. The platform supports reimbursement for patient management and includes tools for data capture and sharing through mobile and desktop apps, SDK, API integration, and a range of sensors connected to respiratory medications.
Technical Sentiment Signal: Sell
Current Market Cap: A$11.18M
For detailed information about ADR stock, go to TipRanks’ Stock Analysis page.